(Q72198398)

English

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

scientific article published on 01 May 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

based on heuristic

inferred from title

author name string

J Y Reginster

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

R Deroisy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M P Lecart

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

N Sarlet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

B Zegels

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

I Jupsin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M de Longueville

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

P Franchimont

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

452-458

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Calcitonin for prevention of postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Thyrocalcitonin and bone resorption. Studies employing a tissue culture bioassay

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Effect of calcitonin on bone mass and fracture rates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Measurement of bone mineral content (BMC) of the lumbar spine, I. Theory and application of a new two-dimensional dual-photon attenuation method

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Diagnostic procedures in disorders of calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Dual photon absorptiometry of lumbar spine in west European (Belgian) postmenopausal females: normal range and fracture threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Prevention of postmenopausal bone loss by tiludronate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

An evaluation of antibodies and clinical resistance to salmon calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Treatment of Paget's Disease with the Calcitonins*

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

A Double-blind Trial of Synthetic Salmon Calcitonin in the Treatment of Acute Pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980344-1

7 January 2021

Identifiers

10.1016/S0002-9343(99)80344-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7733123%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72198398&oldid=1831216377"